XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.25.3

EARNINGS (LOSS) PER SHARE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Schedule of calculation of earnings (loss) per share | Earnings (loss) per share attributable to Bausch Health Companies Inc. is calculated as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in millions, except per share amounts) | 2025 |  | 2024 |  | 2025 |  | 2024
Net income (loss) attributable to Bausch Health Companies Inc. | $ | 179 |  |  | $ | (85) |  |  | $ | 269 |  |  | $ | (139) |
Basic weighted-average common shares outstanding | 371.3 |  |  | 368.4 |  |  | 370.6 |  |  | 367.7 |
Diluted effect of stock options and RSUs | 4.2 |  |  | — |  |  | 3.5 |  |  | — |
Diluted weighted-average common shares outstanding | 375.5 |  |  | 368.4 |  |  | 374.1 |  |  | 367.7 |
Earnings (loss) per share attributable to Bausch Health Companies Inc. |  |  |  |  |  |  |
Basic | $ | 0.48 |  |  | $ | (0.23) |  |  | $ | 0.73 |  |  | $ | (0.38) |
Diluted | $ | 0.48 |  |  | $ | (0.23) |  |  | $ | 0.72 |  |  | $ | (0.38) |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration